MAR 24, 2021 3:12 AM PDT

Three Compounds May Be Suitable for SARS-CoV-2

WRITTEN BY: Nouran Amin

Researchers have found that that three common antiviral and antimalarial therapeutics may be effective in vitro at targeting replication of SARS-CoV-2 that leads to COVID-19.

"We were looking for compounds that could block the entry of the virus into the cell," says Ana Puhl, senior scientist at Collaborations Pharmaceuticals and co-corresponding author of the research. "We chose these compounds because we know that other antivirals which successfully act against Ebola are also effective inhibitors of SARS-CoV-2."

These drugs were previously proven effective against Ebola and the Marburg virus: tilorone, quinacrine and pyronaridine. The compounds were tested against SARS-CoV-2 in multiple cell lines.

Learn more about SARS-CoV-2:

"In the human-derived cell lines, we found that all three compounds worked similarly to remdesivir, which is currently being used to treat COVID-19," says Frank Scholle, associate professor of biology at NC State and co-author of the research. "However, they were not at all effective in the Vero cells."

"Researchers saw similar results when these compounds were initially tested against Ebola," says Sean Ekins, CEO of Collaborations Pharmaceuticals and co-corresponding author of the research. "They were effective in human-derived cell lines, but not in Vero cells. This is important because Vero cells are one of the standard models used in this type of testing. In other words, different cells lines may have differing responses to a compound. It points to the necessity of testing compounds in many different cell lines to rule out false negatives."

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JAN 24, 2021
Drug Discovery & Development
Finding New Cancer Drugs
JAN 24, 2021
Finding New Cancer Drugs
Cells in our body share the same genes. But how those genes are expressed can dictate the fate of a cell. For ...
JAN 26, 2021
Drug Discovery & Development
Gut Microbiota Reveals Drug Activity
JAN 26, 2021
Gut Microbiota Reveals Drug Activity
Inflammatory bowel diseases cannot be entirely cured but instead, the symptoms are treated with anti-inflammat ...
FEB 06, 2021
Cannabis Sciences
Cannabis Reduces Disruptive Behavior in 50% of Young People with Autism
FEB 06, 2021
Cannabis Reduces Disruptive Behavior in 50% of Young People with Autism
Current pharmacotherapies for disruptive behaviors among those with autism are relatively ineffective. Now though, resea ...
FEB 18, 2021
Cell & Molecular Biology
Inhibition of a Specific Enzyme Could be a Way to Treat Glioblastoma
FEB 18, 2021
Inhibition of a Specific Enzyme Could be a Way to Treat Glioblastoma
Researchers may have identified a new treatment target for a deadly form of brain cancer. Inhibiting an enzyme called PR ...
MAR 04, 2021
Drug Discovery & Development
How Placebo Drugs for Pain Work in the Brain
MAR 04, 2021
How Placebo Drugs for Pain Work in the Brain
Researchers from Dartmouth College have found that pain relief drugs that work via the placebo effect reduce pain-relate ...
MAR 30, 2021
Microbiology
A Marburg Virus Treatment Approach is Identified
MAR 30, 2021
A Marburg Virus Treatment Approach is Identified
Marburg virus causes severe hemorrhagic fever; its fatality ratio can be as high as 88 percent. Researchers may have now ...
Loading Comments...